Thrivent Financial for Lutherans
EVO icon

Thrivent Financial for Lutherans’s Evotec EVO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,886
Closed -$68K – 2622
2026
Q1 		$68K Buy
+27,886
New +$89.9K ﹤0.01% 2510
2025
Q4 		– Sell
-14,502
Closed -$53K – 2586
2025
Q3 		$53K Buy
+14,502
New +$55.1K ﹤0.01% 2358

Other funds holding EVO

DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

Thrivent Financial for Lutherans's EVO Position: Q2 2026 in Review

Thrivent Financial for Lutherans sold out of Evotec (EVO) in Q2 2026, closing a stake of 27,886 shares — an estimated $68K sold.

Thrivent Financial for Lutherans first reported a position in EVO in Q3 2025 and held it in 2 quarters. The position peaked at $68K in Q1 2026. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • Thrivent Financial for Lutherans reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 27,886 Evotec shares in Q2 2026, an estimated $68K.
  • Thrivent Financial for Lutherans first reported a position in Evotec in Q3 2025 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's Evotec position peaked at $68K in Q1 2026.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.